UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NVAX — Novavax Inc
CIK 861177
NEW YORK, NY
Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,281,795
+$155,092 QoQ
Shares Held
242,229
-7.3% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 263 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,243 across 206 Biotechnology names. NVAX ranks #94 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,281,795 | 242,229 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,126,703 | 261,266 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,673,204 | 248,989 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,511,470 | 289,674 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,807,194 | 445,587 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,004,974 | 312,789 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,160,215 | 268,684 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,833,222 | 224,325 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,225,512 | 254,780 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $411,388 | 86,065 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $339,805 | 70,793 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $725,547 | 100,214 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $988,812 | 133,084 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $922,269 | 133,084 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,022,159 | 99,432 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,803,326 | 99,084 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,027,849 | 117,205 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,200,566 | 219,967 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,339,766 | 219,052 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $45,684,900 | 220,370 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $62,776,454 | 295,683 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $31,171,538 | 171,924 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $23,050,899 | 206,716 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $18,260,332 | 168,531 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,867,105 | 46,396 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||